Abstract
he International Obesity Task Force has relied heavily on funding from the drug industry for a decade, despite being widely seen as an independent think tank and having ties to the World Health Organization.
Set up in the mid-1990s with help from grants from three drug companies, the task force aims to portray obesity as a “serious medical condition” and to promote better prevention and management strategies.
Set up in the mid-1990s with help from grants from three drug companies, the task force aims to portray obesity as a “serious medical condition” and to promote better prevention and management strategies.
Original language | English |
---|---|
Pages (from-to) | 1412-1412 |
Number of pages | 1 |
Journal | BMJ (Clinical research ed.) |
Volume | 332 |
Issue number | 7555 |
DOIs | |
Publication status | Published - 17 Jun 2006 |